Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
RVC to run epilepsy diet trial
College to investigate the effect of diet on canine condition

The Royal Veterinary College (RVC) is to run a new trial, which will investigate the effect of diet on canine idiopathic epilepsy. Holger Andreas Volk, an RVC lecturer and clinical director at the centre, said: “The influence of diet on epilepsy severity and quality of life is established in humans, with many diets having been shown to improve seizure control. 


“However, there is little data to support the use of diets in veterinary medicine. A new diet has been developed that could improve the management of epileptic dogs, not only by reducing seizure frequency, but especially by improving quality of life and decreasing the level of side effects seen with standard antiepileptic drugs."

The newly developed diet is being trialled on epileptic dogs being treated with phenobarbitone and/or potassium bromide, in order to test its efficacy and safety.

Staff at the college, however, have only managed to recruit half the sample size they need to test the diet, and are now calling on vets and vet nurses to suggest any patients they believe are suitable. Volk added: “We need your help to recruit more dogs. The food is very well tolerated and liked by the dogs on the study.”

According to staff, participating dogs must be aged between 6 months and 11 years old, have had at least three seizures in the last three months and be receiving at least phenobarbital. They must also be suspected of having idiopathic epilepsy, including an unremarkable MRI, and be in good general health, with an unremarkable interictal.

For more information on the trial, the RVC have asked vets and vet nurses to email the Clinical Investigations Centre.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.